Peptide Atlas · Peptide

Vilon

Vilon is the dipeptide Lys-Glu; in mice given the carcinogen 1,2-dimethylhydrazine, tumours developed in 14.3% of treated animals against 60% of controls.

preclinical

provisional
PubChem 7010502
2 citations
0 discussions
0 followers
KE dipeptide
Lysylglutamate
Lysylglutamic acid
Normophthal

Follow this molecule Ask the Hunter-Gatherer

What the evidence says

six tiers, never blended

preclinical — animal, cell or mechanistic work — not yet about people

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

- preclinical
  Claim: Thymic dipeptide Lys-Glu in ageing CBA mice standing
- resolved
Effect of synthetic thymic and pineal peptides on biomarkers of ageing, survival and spontaneous tumour incidence in female CBA mice.
Anisimov VN, Khavinson VK, Mikhalski AI, Yashin AI
pmid 11163623
- preclinical
  Claim: Vilon (Lys-Glu) and chemically induced neoplasia in mice (Russian-language journal) standing
- resolved
[The effect of vilon (Lys-Glu) on 1.2-dimethylhydrazine-induced neoplasia].
Pliss GB, Mel'nikov AS, Malinin VV, Khavinson VKh
pmid 16308980

A claim's standing is its latest row in an append-only history; a tombstone names the later evidence and the reason. The Graveyard and the Resurrection Yard.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.